Clinical trial
Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis…
NCT00361179 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00361179 |
|---|---|
| Title | Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C |
| Official title | An Extension, Observational Protocol to Evaluate the Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C in the Original Study ML17862 |
| Lead sponsor | National Taiwan University Hospital, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Coinfection With Hepatitis B Virus and Hepatitis C Virus, Monoinfection With Hepatitis C Virus |
| Enrollment | 320 |
| Start date | May 1, 2006 |
| Completion | Dec 1, 2011 |
| First posted | Aug 7, 2006 |
| Last update posted | Aug 7, 2006 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: